Latest AI and machine learning research in brain cancer for healthcare professionals.
Malignant tumors present a significant global health challenge, and accurate pathological grading is essential for personalized treatment. Traditional grading methods, which rely on invasive biopsies, are limited by tumor location. In contrast, magnetic resonance imaging (MRI) offers a non-invasive, high-resolution tool with multi-sequence MRI (e.g., T1, T2, T1C) enabling comprehensive tumor asses...
Glioblastoma (GBM) is an aggressive brain tumor with highly variable patient outcomes due to pronounced molecular heterogeneity. Prognosis remains dismal (median survival ∼15 months) and current prognostic models often function as "black boxes," lacking interpretability and limiting clinical utility. There is an urgent need for interpretable prognostic tools to better stratify GBM patients. This s...
BACKGROUND: DNA mutations are the fundamental engines of cancer, driving its initiation and progression. The forces that fuel malignancy are also the ...
Fluorescence-guided surgery (FgS) is increasingly used across oncologic specialties to enhance intraoperative visualisation of tumour tissue and lymph...
BACKGROUND: Combination immune checkpoint inhibitors are recommended as first-line therapy for advanced hepatocellular carcinoma. However, only a thir...
Objective. Accurate segmentation of the prostate and dominant intraprostatic lesions (DILs) on magnetic resonance imaging (MRI) is important for prost...
Personalizing radiotherapy dose in breast cancer remains a major unmet need, as current treatment paradigms rely on uniform prescriptions that overloo...
BACKGROUND & AIMS: In hepatocellular carcinoma (HCC) with cirrhosis, portal hypertension worsens outcomes. Esophagogastroduodenoscopy (EGD), the curre...
Effective radiation monitoring is crucial for ensuring public security and safety, particularly in the event of nuclear (e.g., nuclear accident, fallo...
OBJECTIVES: To test the feasibility of 60 kVp double-low-dose coronary CT angiography (CCTA) with a deep learning reconstruction (DLR) algorithm. MATE...
PURPOSE: Low-grade gliomas(LGGs) show significant clinical and molecular heterogeneity, complicating progression prediction with conventional indicato...
RATIONALE AND OBJECTIVES: To evaluate the impact of a deep learning reconstruction (DLR) algorithm combined with contrast-enhancement boost (CE-boost)...
In the face of emerging threats from natural disasters, nuclear accidents, and potential malicious use of radiation, the National Institute of Allergy...
Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors originating from neural crest-derived chromaffin tissue, marked by clinica...
BACKGROUND AND PURPOSE: Recent studies have demonstrated bias in various medical imaging artificial intelligence (AI) models, yet the factors underpin...
Classification of tumors in neuro-oncology today relies on molecular patterns (mostly DNA methylation) and their machine learning-supported interpreta...
BACKGROUND: Synthetic positron emission tomography (PET) imaging, enabled by deep learning, represents a promising approach to minimize radiation expo...
Segmenting glioblastoma in medical imaging remains challenging due to the tumor's irregular shape, heterogeneous texture, and poorly defined boundarie...